2012
DOI: 10.1331/japha.2012.12108
|View full text |Cite
|
Sign up to set email alerts
|

Making pharmacogenetic testing a reality in a community pharmacy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
27
0
1

Year Published

2013
2013
2021
2021

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 36 publications
(29 citation statements)
references
References 11 publications
1
27
0
1
Order By: Relevance
“…Although expansion of the model as described previously is plausible, barriers to PGt testing in the community pharmacy have been identified. 10 Most notably, we were able to overcome several of the barriers in this model. For example, pharmacists in the current study were able to order the genotyping test through collaborative practice with a local medical group under the study protocol.…”
Section: Discussionmentioning
confidence: 90%
“…Although expansion of the model as described previously is plausible, barriers to PGt testing in the community pharmacy have been identified. 10 Most notably, we were able to overcome several of the barriers in this model. For example, pharmacists in the current study were able to order the genotyping test through collaborative practice with a local medical group under the study protocol.…”
Section: Discussionmentioning
confidence: 90%
“…Oral chemotherapy services, wellness services, cognitive memory screening, psychotherapy, pharmacogenetic testing, health education, concordance, counselling, medication therapy management (MTM), follow-up and referral services Determine educational and training opportunities for community pharmacists, thereby improve patient-centred experiences that supplement their confidence, knowledge, and skill in providing advanced pharmacy services [35][36][37][38][39][40][41][42][43][44][45][46] Surgical department Cardiopulmonary resuscitation (CPR) Determine pharmacist participation on CPR teams in health care delivery organizations [47,48] Regulatory scrutiny Drug Pricing Evaluate and monitor drug pricing through the use key metrics on cost savings achieved, maintenance costs, and other aspects of program involvement [49] In-patient Pharmaceutical care Provision of pharmaceutical care, identification of drug therapy problems, prevention of adverse drug reactions and monitoring of drug therapy management [48,50,51] Out-patient department Ambulatory care, patient education Assertively advancing ambulatory care practice, to achieve the national priorities of improving patient care, adherence, patient health, and affordability of care [48,52,53] Pediatric department Pediatric care Provision of advanced pediatric care [48,54] Intensive care units and oncology department Palliative care services Introducing the concept of 'advanced practice roles' in pharmacy within the new integrated regionalized palliative care service [48,55,56] …”
Section: Peculiar Advanced Pharmacy Practice Servicesmentioning
confidence: 99%
“…Pharmacogenetics, relating variation in drug response to a specific gene, is gaining acceptance as support data in therapeutic decision making. [1][2][3][4] In fact, the Clinical Pharmacogenetics Implementation Consortium (CPIC) has published dosing guidelines related to specific gene-drug pairs. 5,6 These guidelines are intended to help clinicians apply PGt data in therapeutics to maximize drug efficacy and minimize or avoid adverse drug reactions.…”
Section: Introductionmentioning
confidence: 99%
“…Increasingly, pharmacy students will be required to apply the science of PGt to clinical practice. [1][2][3][4] To address this, colleges of pharmacy continue to develop their curricula in PGt, with approximately 90% of schools including the subject matter in their Doctor of Pharmacy curricula as of 2009; an increase from 39% as reported in 2005. 10,11 However, only 2.9% of colleges of pharmacy required a PGt laboratory exercise.…”
Section: Introductionmentioning
confidence: 99%